SenoGuard
PrivateLast Round
SAFE
Jul 31, 2025
Est. Valuation
$5M
Total Funding Raised
$1.26M
Company Overview
SenoGuard is a medical device company developing a radiation-free cryoablation treatment for breast cancer patients following lumpectomy surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SenoGuard Comparables
Compare SenoGuard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innoblative Designs, Inc. | 86% | |
| Sanarus Technologies | 77% | |
| Novian Health | 72% | |
SenoGuard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jul 31, 2025 |
SenoGuard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2025
$1.2M raised in SAFE round.
SenoGuard Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SenoGuard's valuation, stock price, and market status.